SBP solbec pharmaceuticals limited

genentech up $11 billion, page-15

  1. 5,882 Posts.
    lightbulb Created with Sketch. 150
    re: skint/refresher 4-6 weeks to USA listing is good . At least in the USA there are drugs to compare with Coramsine . To get a partial response in 16% of patients against mixed refractory tumours is unusual . To find the ones that compare in their first phase 1 against solid mixed tumours is easy . Just research all the blockbusters .
    Cheers
 
watchlist Created with Sketch. Add SBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.